Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Suxamethonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.95 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.95 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.67 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.67 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.64 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.62 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.62 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.62 |
| ▸ | HTR1A | P08908 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | PGR | P06401 | 1/20 | 0.62 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.62 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.62 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.62 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Suxamethonium SCHEMBL20815392 | 0.98 | MAPT (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL1983256 | 0.98 | MAPT (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL41537 | 0.97 | ADRA2A (1.00) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL16320883 | 0.95 | ADRA2A (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL21356923 | 0.95 | ADRA2A (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL1643328 | 0.95 | ADRA2A (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL2821312 | 0.95 | ADRA2A (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Suxamethonium SCHEMBL2690356 | 0.95 | ADRA2A (0.95) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Hydrochloric Acid SCHEMBL25376349 | 0.91 | MAPT (0.83) | MAPTBLMADRA2AADRA1ACHRM5 | |
| Hydrochloric Acid SCHEMBL28824833 | 0.91 | MAPT (0.83) | MAPTBLMADRA2AADRA1ACHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5319 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4076560-B1 | SURFACE MODIFYING COATING FOR MEDICAL DEVICES | HOSPIRA INC (US) | 2026-04-01 | — | — | EP | claimed |
| WO-2025229061-A1 | COMPOSITION FOR ANTI-GRAFFITI COATING AND METHOD FOR PREPARING THE COMPOSITION | O2-TABS DESINFEKTION GMBH (DE) | 2025-11-06 | — | — | WO | claimed |
| US-12295932-B2 | Succinylcholine chloride prefilled syringe | HIKMA PHARMACEUTICALS USA INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119125347-A | Method for detecting succinylcholine chloride intermediate and related impurities | 上海旭东海普药业有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-12133912-B2 | Stable pharmaceutical compositions of succinylcholine chloride | Slayback Pharma LLC. (US) | 2024-11-05 | — | — | US | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| US-20240108571-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF SUCCINYLCHOLINE CHLORIDE | Slayback Pharma LLC. (US) | 2024-04-04 | — | — | US | claimed |
| CN-115216620-B | Method for recovering nickel, cobalt and manganese from waste ternary lithium battery by fractional precipitation | 埃索凯循环能源科技(广西)有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117418106-A | Method for recovering lithium nickel cobalt manganese in waste ternary lithium battery by step leaching method | 埃索凯循环能源科技(广西)有限公司 | 2024-01-19 | — | — | CN | claimed |
| US-11872305-B2 | Stable pharmaceutical compositions of succinylcholine chloride | AZURITY PHARMACEUTICALS, INC. | 2024-01-16 | — | — | US | claimed |
| EP-0391993-A1 | LUBRICANT COMPOSITIONS AND ADDITIVE CONCENTRATES FOR THEIR PREPARATION. | LUBRIZOL GENETICS INC (US) | 1990-10-17 | — | — | EP | claimed |
| EP-0379566-A1 | LUBRICATING OIL COMPOSITIONS. | LUBRIZOL CORP (US) | 1990-08-01 | — | — | EP | claimed |
| WO-1990004626-A2 | LUBRICANT AND FUNCTIONAL FLUID COMPOSITIONS EXHIBITING IMPROVED DEMULSIBILITY | THE LUBRIZOL CORPORATION (US) | 1990-05-03 | — | — | WO | claimed |
| WO-1989012668-A1 | LUBRICATING OIL COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1989-12-28 | — | — | WO | claimed |
| EP-0329994-A1 | Immunogen and its use in preparing antibodies to haemoglobin A1C | Roche Diagnostics GmbH (DE) | 1989-08-30 | — | — | EP | claimed |
| US-4726594-A | Drug injection system for use with an arrow | BENKE GUS A (US) | 1988-02-23 | — | — | US | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
| EP-0147780-A2 | Drug delivery device | MERCK & CO. INC. (US) | 1985-07-10 | — | — | EP | claimed |
| EP-0126684-A2 | Drug delivery system utilizing thermosetting gels | MERCK & CO. INC. (US) | 1984-11-28 | — | — | EP | claimed |
| US-4474752-A | DIAMINE MODIFIED POLYOXYETHYLENE-POLYOXYPROPYLENE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |